Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla

L Chaabane1, N Pellet, M C Bourdillon

  • 1Laboratoire de RMN UMR CNRS 5012, UCB Lyon1-ESCPE, 69622, Villeurbanne, France.

Magma (New York, N.Y.)
|November 27, 2004
PubMed

Insights

Dynamic contrast-enhanced MRI effectively visualizes early atherosclerotic plaque development in mice. This method tracks contrast uptake, revealing variations in plaque activity and vessel permeability during atherogenesis.

Area of Science:

  • Biomedical Imaging
  • Cardiovascular Research
  • Mouse Models

Background:

  • Atherosclerosis is a progressive disease affecting arteries.
  • Early detection of atherosclerotic plaque development is crucial.
  • Mouse models, like apoE-/- mice, are vital for studying atherogenesis.

Purpose of the Study:

  • To develop and evaluate a Magnetic Resonance Imaging (MRI) method.
  • To assess contrast enhancement in early atherosclerotic plaque development.
  • To investigate plaque activity in the abdominal aorta of a mouse model.

Main Methods:

  • Utilized male apoE-/- mice at 4, 8, and 16 weeks of age.
  • Acquired axial T1 spin echo MRI images of the abdominal aorta.
  • Administered a macromolecular contrast agent and performed dynamic imaging for over 1 hour.

Main Results:

  • Maximal arterial wall signal enhancement occurred 16-32 minutes post-injection.
  • Signal-to-noise ratio increased significantly, especially in younger mice.
  • Contrast enhancement was less pronounced in older mice with advanced lesions, suggesting altered vessel permeability.

Conclusions:

  • Dynamic contrast-enhanced MRI can evaluate atherosclerotic plaque activity in mice.
  • Contrast uptake varies with lesion stage and may correlate with vessel-wall permeability.
  • This MRI technique offers a valuable tool for studying early atherogenesis.

Related Concept Videos